Allergex Non Drowsy

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allergex Non Drowsy

This section provides a factual overview of the identity, composition, and fundamental classification of the pharmaceutical preparation known as Allergex Non Drowsy, which contains the active substance Loratadine.

Property Description
Active ingredient Loratadine
Form Tablet, Syrup, Oral solution
Pharmacological class Second-Generation Antihistamine
General purpose Relief from histamine-mediated symptoms
Origin Synthetic (Tricyclic compound)

What Type of Medicine is Allergex Non Drowsy?

Allergex Non Drowsy is a recognized pharmaceutical preparation classified as a Second-Generation Antihistamine, which functions primarily as a highly selective Peripheral H1 Blocker to relieve symptoms associated with common allergic conditions. This pharmacological class exhibits efficacy against histamine-mediated responses, distinguishing it from older analogue substances. This specific classification is crucial to its designation as a non-sedating treatment, reflecting its structural refinement to minimize central nervous system effects.

Composition, Origin, and Available Forms

The core of this medicine is the synthetic active substance Loratadine, a tricyclic compound derived from the piperidine family that is used here as a single-ingredient product. The formulation is intended for oral administration and is typically presented in various pharmaceutical preparations, including a standard Tablet, a liquid Syrup, and an Oral solution. Loratadine is a long-acting compound that provides relief by inhibiting peripheral H1-receptors. This feature underscores the preparation’s extended duration of action, a key factor in its patient-focused positioning.

General Purpose and Mechanism Principle

Clinically recognized for providing targeted relief, the general purpose of the medication is to stabilize the body's reaction to allergens through a process of selective antagonism against histamine, the body’s primary chemical mediator for allergic responses. By specifically blocking the H1 receptor sites, the Loratadine molecule prevents histamine from attaching and initiating the chain of events. This selective action achieves the desired anti-allergic effect that mitigates histamine-mediated symptoms generally, while maintaining its status as a non-sedating antihistamine.

Regulatory References

  1. Loratadine - DailyMed - NIH
  2. MedlinePlus Loratadine Information

What side effects are possible with Allergex Non Drowsy?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of Loratadine, the active substance in Allergex Non Drowsy, as classified in regulatory documents.

Adverse Reaction Frequencies

Side effects are categorized by frequency based on data from clinical trials and post-marketing surveillance, spanning several System-Organ Classes (SOC) including nervous system, gastrointestinal, and cardiac disorders.

Classification Examples of Reactions Affected Systems (SOC)
Common (Adults/Adolescents) Headache, Somnolence (drowsiness), Insomnia, Increased appetite Nervous System, Metabolism
Common (Children 2-12) Headache, Nervousness, Fatigue Nervous System, General Disorders
Very Rare Convulsion, Tachycardia, Abnormal hepatic function, Rash, Alopecia Nervous System, Cardiac, Hepatobiliary, Skin

Serious Adverse Reactions

The label documents specific reactions as serious, although they are classified as Very Rare. These include Hypersensitivity Reactions (such as Angioedema and Anaphylaxis), Convulsion, and Abnormal Hepatic Function.

Safety Considerations for Specific Populations

Safety notes are explicitly defined for specific user groups. Caution is necessary for individuals with severe liver problems or kidney disease, as substance elimination may be altered. The medicine is not recommended for women who are breastfeeding, as the active substance is excreted into breast milk. Safety and efficacy have not been established for children younger than 2 years.

Safety Restrictions and Limitations

Official labeling notes that the substance may interfere with allergy skin tests, recommending temporary cessation before testing. Furthermore, while the medicine is non-sedating, the very rare potential for reduced alertness means caution is specified when performing attention-demanding activities like operating machinery.

Overdose and Emergency Response

The official regulatory documentation for Loratadine specifies the required actions and documented manifestations in the event of an overdose. The most commonly reported clinical signs following ingestion of amounts greater than directed include somnolence (drowsiness), headache, and tachycardia (rapid heart rate). Overdosage may also present with signs consistent with general anticholinergic effects.

If an overdose is suspected, official guidance mandates that individuals seek immediate medical attention and contact a Poison Control Center right away. Due to the documented potential for rare, severe outcomes, including convulsions or cardiac disturbances, the patient is required to undergo continued medical monitoring in a clinical setting.

In the case of over-ingestion, no specific antidote is known for Loratadine. Clinical management is strictly focused on general symptomatic and supportive measures. Procedures such as the administration of activated charcoal slurry or gastric lavage may be initiated to prevent further absorption of the substance. Regulatory sources further note that Loratadine is not removed by haemodialysis. In children, specific manifestations like extrapyramidal signs and palpitations have been reported following overdosage of the liquid formulation.

Therapeutic Uses of Allergex Non Drowsy

What Allergex Non Drowsy Treats: Main Uses and Benefits

Allergex Non Drowsy is commonly used to provide symptomatic relief in conditions involving inflammatory or irritative processes, specifically addressing allergic rhinitis (hay fever) and Chronic Idiopathic Urticaria (hives). This medicine is applied in addressing symptom clusters that may become disruptive, such as sneezing, runny nose (rhinorrhoea), nasal pruritus, and ocular symptoms like itchy, watery eyes, and skin itching (pruritus).

Its application is relevant for easing these symptoms during episodes of heightened allergen exposure. The medicine's duration of effect generally assists with maintaining functional stability when symptoms are more noticeable, supports a more comfortable daily experience, and contributes to easing the overall symptom load during recurrent episodes.

“This medication is considered relevant for managing acute and chronic manifestations where symptoms interfere with daily comfort.”

Quick Fact: Relief for Nasal and Ocular Symptoms

Quick Fact: Relief for Nasal and Ocular Symptoms. This medicine is applied across domains where additional symptomatic support is needed to address discomfort stemming from seasonal pollen and perennial indoor allergens.

Regulatory References

  1. NIH MedlinePlus overview of Loratadine

Eligibility and Restrictions for Use

The eligibility for using Allergex Non Drowsy (Loratadine) is defined by official regulatory documents across specific age groups and health conditions.

Eligibility Scope

  • Populations for whom use is allowed: Adults and adolescents (ge 12 years) are approved for standard use. Children ge 6 years may use the 10 mg formulations, while children aged 2 to 5 years require a lower dose, typically using liquid formulations.
  • Populations for whom use is contraindicated: The medicine is strictly contraindicated in patients with a known hypersensitivity to Loratadine or any excipients. Use is also contraindicated in children under 2 years of age as safety and efficacy are not established. Certain tablet formulations are prohibited for patients with rare hereditary metabolic conditions like galactose intolerance.

Condition-Specific Restrictions

Official labeling requires restricted use for individuals with severe hepatic (liver) impairment or severe renal (kidney) insufficiency (GFR <30 mL/min). For these populations, a reduced starting dose, such as 10 mg every other day, is generally required. Certain chewable or orally disintegrating tablets are not recommended for patients with Phenylketonuria (PKU) due to the presence of phenylalanine.

Pregnancy and Lactation Status

Use during pregnancy is generally preferable to avoid as a precautionary measure. Use is not recommended while breastfeeding, as Loratadine and its active metabolite are excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Allergex Non Drowsy (loratadine) has documented interactions primarily relating to its metabolism and effects on the central nervous system (CNS).

Documented Interaction Domains

Interaction Domain Mechanism and Regulatory Implication
Inhibitors of Hepatic Metabolism Specific medicines inhibit the liver enzymes responsible for loratadine's breakdown, potentially increasing loratadine concentrations. Official guidance advises against the concomitant use of these specific inhibitors.
CNS Depressants and Alcohol Co-administration may result in additive central nervous system effects, such as increased sedation. Caution and monitoring are required.

Specific Interacting Substances

Official regulatory documentation identifies a list of specific medicines that may significantly alter loratadine plasma concentrations by inhibiting its metabolism. These include cimetidine, erythromycin, ketoconazole, quinidine, fluconazole, and fluoxetine. Concomitant administration with these medicines is generally not recommended as it can raise exposure to loratadine.

Simultaneously consuming alcohol or other medicines that depress the central nervous system requires careful consideration due to the potential for compounding effects on functions like alertness. Patients with documented hepatic impairment may also experience decreased clearance of loratadine and should be managed accordingly. The overall interaction profile is structured around avoiding combinations that significantly raise drug levels and using caution with substances that compound CNS effects.

Mechanism of Action

Blocking the Histamine-1 Pathway

The active component of this medication operates by directly influencing key regulatory systems associated with histamine-mediated signaling. It functions as a highly selective antagonist at peripheral H1 receptors. This interaction involves rapid binding to the receptor, which suppresses signaling sequences where the inflammatory mediator, histamine, dominates.

Modulating Histamine-Driven Cascades

By blocking the H1 receptor, the drug modifies early molecular steps characteristic of histamine-driven cascades. This activity modulates pathways driven by distinct signaling patterns and results in the attenuation of histamine-mediated physiological consequences, including increased vascular permeability and sensory nerve stimulation in peripheral tissues.

Restricted Central Pathway Activity

The targeted effect modulates excessive signaling within peripheral pathways while maintaining limited central nervous system (CNS) pathway activity. This specificity is achieved due to limited penetration of the blood-brain barrier, which restricts interaction with central H1 receptors and minimizes CNS signaling.

Dosage and Administration Information

How to Use Allergex Non Drowsy: Official Administration Guidelines

The administration of Loratadine (the active ingredient in Allergex Non Drowsy) follows specific parameters defining the route, dosage, and frequency patterns for standardized use. This medicine is approved for oral administration and is typically presented in forms such as a 10 mg conventional Tablet or a Syrup/Oral Solution.


Labeled Dosing and Frequency

The dosage schedule is based on age and is structured around a once-daily (qDay) frequency. The maximum recommended dose is 10 mg within a 24-hour period.

Population Standard Daily Dose Frequency
Adults and Children 6 years 10 mg Once daily
Children 2-5 years 5 mg Once daily

Special Administration Conditions

Administration is generally flexible concerning meals, as the medication may be taken with or without food. For patients with documented severe hepatic impairment or renal impairment (Glomerular Filtration Rate < 30 mL/ min), an adjusted dosing schedule is used. In such cases, the standard 10 mg dose is administered every other day to accommodate the body’s reduced capacity to process the substance. If a liquid form is administered, a calibrated measuring device must be used to ensure the volume is accurate.

Recent Clinical Evidence

Research evidence / Overview of studies for Allergex Non Drowsy

Research related to the active substance Loratadine includes studies that examined its use in specific allergic conditions. This overview focuses strictly on the structure of the clinical evidence, the type of research that has been conducted, and what those findings describe, without offering any clinical advice or interpretation.


Evidence for Use in Allergic Rhinitis (Hay Fever)

Research for this indication involves numerous short-term Randomized Controlled Trials (RCTs) exploring symptom changes in conditions characterized by fluctuating manifestations like hay fever. Studies were designed to monitor outcomes related to physical discomfort, specifically by measuring changes in nasal symptoms and to examine outcomes reflecting daily functioning. Findings describe patterns observed over observation periods, typically up to two weeks. The data contributed to the separate regulatory review for symptom clusters. Comparative research noted that evidence quality varies across studies, sometimes describing inconsistent results versus other antihistamines.


Evidence for Use in Chronic Hives (Idiopathic Urticaria)

For Chronic Idiopathic Urticaria, research includes RCTs and systematic reviews. These studies monitored patient-reported outcomes describing perceived discomfort related to skin irritative states. The research explored short-term symptom changes and aimed to measure the overall therapeutic response. Research highlights changes measured during the study period in the level of itch and the appearance of hives. Analysis of comparative trials noted that study design variability led to limitations when attempting to pool findings.


The Current State of Evidence: Gaps and Limitations

Research has explored the use of Loratadine across age groups, including Adults, Adolescents, and Children (2 to <12 years). However, evidence is limited for research involving children younger than two years. The majority of pivotal regulatory research was evaluated in settings relevant to short-term symptom patterns. Follow-up durations were limited, often lasting only for days or a few weeks. Consequently, long-term effects are not fully established, and there is limited information for long-term outcomes when considering the maintenance of daily functioning beyond the clinical trials.

Key Studies & References

  1. Loratadine - StatPearls (Source for dosing and age-related evidence, including data for children and liver/kidney impairment)

Frequently Asked Questions (FAQ)

Common questions about Allergex Non Drowsy (FAQ)

Q: How quickly does Allergex Non Drowsy start to work?

A: Studies included in official regulatory documents show that the antihistaminic effects of the active substance, Loratadine, typically begin within 1 to 3 hours after taking an oral dose. This timeframe describes the expected onset of the active substance's anti-histaminic action.

Q: How long do the effects of Allergex Non Drowsy usually last?

A: Official information indicates that the anti-allergic effect of a single dose generally lasts for more than 24 hours. The duration of effect is a function of the medicine’s structure and how the body processes it.

Q: Is it possible to take Allergex Non Drowsy at night?

A: Regulatory instructions define the medication as a once-daily treatment. Because the product is generally non-sedating, it may be taken flexibly at any time of day, including at night, with or without food.

Q: Is Allergex Non Drowsy available over the counter?

A: Yes, the product is typically classified as an Over-The-Counter (OTC) medication in many regions. This classification means it is widely available for temporary allergy relief when used according to the label.

Q: Is a prescription needed for Allergex Non Drowsy?

A: The standard 10 mg strength of this medication is often approved for Over-The-Counter (OTC) sale. Therefore, a prescription is generally not required for purchase.

Q: How often can Allergex Non Drowsy be taken?

A: The recommended frequency is once daily. Official frequency guidelines restrict use to no more than one dose within a 24-hour period.

Q: Are there any known interactions with common painkillers and Allergex Non Drowsy?

A: Official health guidance suggests that the active substance has been reviewed in combination with common over-the-counter painkillers, such as ibuprofen or paracetamol.

Q: Does Allergex Non Drowsy contain any decongestants?

A: Official labeling for the standard Allergex Non Drowsy product lists Loratadine as the single active ingredient. Combination products containing decongestants are available separately and have different labeling.

Q: Does taking Allergex Non Drowsy cause weight gain?

A: While increased appetite is noted as a common side effect in adults and adolescents, weight gain itself is not listed among the common side effects in regulatory documents.

Q: Is Allergex Non Drowsy useful for pet allergies?

A: The medication is approved for the temporary relief of symptoms caused by upper respiratory allergies. Since pet dander often triggers perennial allergic rhinitis, the medication’s official scope covers symptoms related to common allergens.

Q: Is Allergex Non Drowsy a steroid?

A: No, the medicine is classified by regulatory bodies as a Second-Generation Antihistamine. It functions as a selective H1-receptor blocker and is not a steroid.

Q: Do I need to take Allergex Non Drowsy with food?

A: According to official product information, the medication may be taken either with or without food. Although taking it with food may slightly affect the rate of absorption, official product information indicates that the overall effect is not significantly changed.

Q: Are there different strengths of Allergex Non Drowsy tablets?

A: The most common tablet strength available is 10 mg. Liquid forms, chewable tablets, and orally disintegrating tablets are often available in 5 mg and 10 mg doses.

Q: Can Allergex Non Drowsy be crushed or split?

A: Regulatory guidance suggests that standard tablets are intended to be swallowed whole. Crushing, chewing, or breaking the tablet is not recommended, especially for specific formulations.

Q: Is Allergex Non Drowsy gluten-free?

A: Some formulations of the active substance, including certain generic and brand-name products, may be explicitly labeled as 'Gluten Free' on the packaging. This detail is based on the specific inactive ingredients listed in the product label.

Q: Does Allergex Non Drowsy interact with specific foods or juices?

A: Official regulatory documents do not include specific warnings about interactions with common fruit juices, such as grapefruit juice. Food is noted as being flexible regarding administration.

Q: Is there a generic version of Allergex Non Drowsy available?

A: Yes, generic versions containing the active substance Loratadine are widely approved and available for purchase Over-The-Counter (OTC).

Q: Is there a link between Allergex Non Drowsy and anxiety or nervousness?

A: Nervousness is listed in official documents as a common side effect found in clinical trial data for children aged 2 to 12 years. This effect is monitored as part of the drug's safety profile.

Q: Does Allergex Non Drowsy have a potential for dependency?

A: The active substance is not classified as a controlled substance and is considered to have a low potential for dependency. However, as with any medication, regulatory sources note that the need for long-term use should be reviewed.

Q: Is there a liquid form of Allergex Non Drowsy for children?

A: Yes, liquid dosage forms, such as a syrup or oral solution, are available. These forms are commonly used for younger children who are within the eligible age range for the medicine.

Q: Can this medication be used for year-round allergy symptoms?

A: Official indications approve the medication for relieving symptoms associated with 'other upper respiratory allergies.' This generally includes perennial allergic rhinitis, which is commonly described as year-round allergies.

Q: Does Allergex Non Drowsy interact with herbal supplements?

A: Caution is advised regarding supplements with known sedative properties, as combining them may increase the rare potential for reduced alertness associated with the active substance.

Q: Is a warning issued about taking Allergex Non Drowsy with grapefruit juice?

A: Official product labeling does not contain a specific warning against combining the active substance with grapefruit juice. This information is based on the drug’s metabolic profile.

Q: What happens if I miss a dose of Allergex Non Drowsy?

A: If a dose is missed, regulatory guidance generally suggests taking it as soon as it is remembered. If it is almost time for the next scheduled dose, regulatory guidance suggests the missed dose may be skipped to maintain the once-daily schedule, without taking two doses at once.

Q: Does 'non drowsy' mean it has no side effects related to sleepiness?

A: The classification 'non-drowsy' is based on the active substance being less likely to cause sedation than older antihistamines. However, official documents list somnolence (drowsiness) as a common side effect in adults and adolescents.

Q: Why is it called 'Non Drowsy' if some people still feel tired?

A: The term reflects that the medication generally causes less sedation compared to first-generation antihistamines. However, the potential for feeling tired or drowsy is a documented common side effect in clinical trial data, indicating that individual responses can vary.

Q: Can this medication affect my ability to drive or use machinery?

A: While generally non-sedating, the official product label notes that caution is specified for activities requiring attention, such as operating machinery or driving. This is due to the very rare potential for reduced alertness documented in the safety profile.

Q: Can I use Allergex Non Drowsy for long periods?

A: Official documents note that pivotal regulatory research was primarily based on short-term relief, meaning that information on long-term effects is limited.

Q: What if I take Allergex Non Drowsy and it doesn't seem to help my symptoms?

A: The medicine is approved for the temporary relief of symptoms. Official labeling states that if temporary relief is not achieved or if symptoms worsen, users are advised to discontinue use and seek professional guidance.

Q: What are some common mild side effects of Allergex Non Drowsy?

A: For adults and adolescents, common mild effects documented in clinical trials include headache, sleepiness (somnolence), and difficulty sleeping (insomnia). Children commonly report headache, nervousness, and fatigue.

Q: Why do some people experience dry mouth when taking Allergex Non Drowsy?

A: Dry mouth is not listed as a common side effect in the official regulatory documents. While antihistamines can sometimes cause anticholinergic effects, dry mouth is not a frequently reported event for this specific medication.

Q: What type of allergies is Allergex Non Drowsy commonly used for?

A: The medicine is officially indicated for the temporary relief of symptoms related to Allergic Rhinitis, which includes hay fever, and Chronic Idiopathic Urticaria, often described as chronic hives.

Q: Can I use Allergex Non Drowsy for hives or skin rashes?

A: Yes, the medication is officially indicated for symptoms associated with Chronic Idiopathic Urticaria, a condition characterized by hives. The active ingredient works to relieve the related histamine-mediated discomfort.

How should Allergex Non Drowsy be stored and disposed of?

Storage Conditions and Handling

Official labeling requires specific conditions for the storage of Allergex Non Drowsy (Loratadine) to maintain stability:

Requirement Specific Condition
Temperature Store at or below 25°C (Syrup/Liquid) or below 30°C (Tablets).
Protection Keep the product protected from light and moisture in a dry place.
Handling Do not freeze the medicine; do not store in a bathroom.
Packaging Keep the medicine in its original container and ensure the cap is tightly closed.
Safety KEEP OUT OF SIGHT AND REACH OF CHILDREN.

The medicine must not be used after the expiry date shown on the label.

Disposal Instructions

To dispose of unused or expired medicine responsibly, official regulations state:

  • Do not dispose of the medicine via wastewater (drains) or household trash.
  • Return all unused or expired medicine to a pharmacist for proper environmental handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allergex Non Drowsy found in:

A-Z Index: